A shocking revelation: Despite medical guidelines, many older adults with dementia are still at risk!
New research reveals a concerning trend in the prescription of medications to older adults with dementia. Even though clinical guidelines have long warned against it, a significant number of Medicare beneficiaries with dementia are being prescribed medications that can have severe side effects, such as falls, confusion, and hospitalization. This is a startling discovery, especially considering the potential harm it poses to vulnerable patients.
The study, to be published in JAMA on January 12, found that one in four dementia patients on Medicare received these brain-altering medications. While the overall prescription rate for these drugs decreased from 20% to 16% over nine years, the problem persists for those with cognitive impairment, who are more likely to experience adverse effects.
But here's where it gets controversial: Despite the decline, the study highlights that over two-thirds of patients receiving these prescriptions in 2021 lacked a documented clinical reason. This suggests a worrying trend of potentially inappropriate and harmful prescribing practices, especially for those with cognitive impairment.
The researchers analyzed data from the Health and Retirement Study linked to Medicare claims to examine the prescription patterns of central nervous system (CNS)-active medications from 2013 to 2021. These medications included antidepressants with anticholinergic properties, antipsychotics, barbiturates, benzodiazepines, and non-benzodiazepine hypnotics.
Interestingly, the prescription rates varied among different cognitive groups. While 17% of older adults with normal cognition received CNS medications, the rate rose to nearly 22% for those with cognitive impairment without dementia, and to a concerning 25% for dementia patients.
And this is the part most people miss: The study also revealed prescription trends for specific medication classes. Benzodiazepines and sleep drugs saw a decline in prescriptions, while antipsychotic prescriptions increased. Anticholinergic antidepressants and barbiturates remained relatively stable.
The findings suggest that while there has been some improvement, there is still much work to be done. The researchers emphasize the importance of careful prescription practices, especially for CNS-active medications, and encourage patients and caregivers to actively engage with healthcare providers to ensure the appropriateness of these medications.
A call to action: As this study highlights, it is crucial to raise awareness about the potential risks of these medications for older adults with dementia. Healthcare providers should be vigilant in their prescribing practices, and patients and caregivers should be empowered to ask questions and seek alternative treatments when necessary. What do you think? Is this an issue that deserves more attention, or are these medications sometimes necessary despite the risks?
